Compared consolidated income statements
| € millions | 2024 | 2023 | 2022 |
|---|---|---|---|
| Sales | Sales 2024 43,486.8 |
Sales 2023 41,182.5 |
Sales 2022 38,260.6 |
| Cost of sales | Cost of sales 2024 (11,227.0) |
Cost of sales 2023 (10,767.0) |
Cost of sales 2022 (10,577.4) |
| Gross profit | Gross profit 2024 32,259.8 |
Gross profit 2023 30,415.5 |
Gross profit 2022 27,683.3 |
| Research & Innovation expenses | Research & Innovation expenses 2024 (1,354.7) |
Research & Innovation expenses 2023 (1,288.9) |
Research & Innovation expenses 2022 (1,138.6) |
| Advertising and promotion | Advertising and promotion 2024 (14,008.9) |
Advertising and promotion 2023 (13,356.6) |
Advertising and promotion 2022 (12,059.0) |
| Selling, general and administrative expenses | Selling, general and administrative expenses 2024 (8,208.7) |
Selling, general and administrative expenses 2023 (7,626.7) |
Selling, general and administrative expenses 2022 (7,028.8) |
| Operating profit | Operating profit 2024 8,687.5 |
Operating profit 2023 8,143.3 |
Operating profit 2022 7,456.9 |
| Other income and expenses | Other income and expenses 2024 (437.7) |
Other income and expenses 2023 (449.9) |
Other income and expenses 2022 (241.5) |
| Operational profit | Operational profit 2024 8,249.8 |
Operational profit 2023 7,693.4 |
Operational profit 2022 7,215.4 |
| Finance costs on gross debt | Finance costs on gross debt 2024 (373.4) |
Finance costs on gross debt 2023 (226.7) |
Finance costs on gross debt 2022 (70.4) |
| Finance income on cash and cash equivalents | Finance income on cash and cash equivalents 2024 148.7 |
Finance income on cash and cash equivalents 2023 162.1 |
Finance income on cash and cash equivalents 2022 69.8 |
| Finance costs, net | Finance costs, net 2024 (224.7) |
Finance costs, net 2023 (64.6) |
Finance costs, net 2022 (0.6) |
| Other financial income and expenses | Other financial income and expenses 2024 (36.7) |
Other financial income and expenses 2023 (48.8) |
Other financial income and expenses 2022 (72.3) |
| Sanofi dividends | Sanofi dividends 2024 444.5 |
Sanofi dividends 2023 420.9 |
Sanofi dividends 2022 468.2 |
| Profit before tax and associates | Profit before tax and associates 2024 8,432.9 |
Profit before tax and associates 2023 8,001.0 |
Profit before tax and associates 2022 7,610.6 |
| Income tax | Income tax 2024 (2,015.1) |
Income tax 2023 (1,810.6) |
Income tax 2022 (1,899.4) |
| Share of profit in associates | Share of profit in associates 2024 (1.3) |
Share of profit in associates 2023 0.2 |
Share of profit in associates 2022 1.4 |
| Net profit | Net profit 2024 6,416.5 |
Net profit 2023 6,190.5 |
Net profit 2022 5,712.6 |
| Attributable to: | Attributable to: 2024
|
Attributable to: 2023
|
Attributable to: 2022
|
| owners of the company | owners of the company 2024 6,408.7 |
owners of the company 2023 6,184.0 |
owners of the company 2022 5,706.6 |
| non-controlling interests | non-controlling interests 2024 7.8 |
non-controlling interests 2023 6.5 |
non-controlling interests 2022 6.0 |
| Earnings per share attributable to owners of the company (euros) | Earnings per share attributable to owners of the company (euros)2024 11.99 |
Earnings per share attributable to owners of the company (euros)2023 11.55 |
Earnings per share attributable to owners of the company (euros)2022 10.65 |
| Diluted earnings per share attributable to owners of the company (euros) | Diluted earnings per share attributable to owners of the company (euros)2024 11.95 |
Diluted earnings per share attributable to owners of the company (euros)2023 11.52 |
Diluted earnings per share attributable to owners of the company (euros)2022 10.61 |
| Earnings per share attributable to owners of the company, excluding non-recurring items (euros) | Earnings per share attributable to owners of the company, excluding non-recurring items (euros)2024 12.70 |
Earnings per share attributable to owners of the company, excluding non-recurring items (euros)2023 12.11 |
Earnings per share attributable to owners of the company, excluding non-recurring items (euros)2022 11.30 |
| Diluted earnings per share attributable to owners of the company, excluding non‑recurring items (euros) | Diluted earnings per share attributable to owners of the company, excluding non‑recurring items (euros)2024 12.66 |
Diluted earnings per share attributable to owners of the company, excluding non‑recurring items (euros)2023 12.08 |
Diluted earnings per share attributable to owners of the company, excluding non‑recurring items (euros)2022 11.26 |
Sources and uses of funds
This diagram shows a breakdown of Gross Cash Flow: Sources and Applications of Funds in 2024.
Sources of Funds(in millions of euros):
- Net profit attributable to owners of the company: 6,408.7
- Amortisation and provisions: 1,855.3
- Capital gains or losses on disposals of assets, changes in deferred taxes and other: 248.6
Total Gross Cash Flow : 8,512.6